United Therapeutics (NASDAQ:UTHR) First Quarter 2024 ResultsKey Financial Results Revenue: US$677.7m (up 34% from 1Q 2023). Net income: US$306.6m (up 27% from 1Q 2023). Profit margin: 45% (down from ...
Source LinkUnited Therapeutics (NASDAQ:UTHR) First Quarter 2024 ResultsKey Financial Results Revenue: US$677.7m (up 34% from 1Q 2023). Net income: US$306.6m (up 27% from 1Q 2023). Profit margin: 45% (down from ...
Source Link
Comments